We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. Food and Drug Administration (FDA) has issued a revised draft guidance in response to comments received on an initial draft guidance for in vitro diagnostic multivariate index assays (IVDMIAs).
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor